S. Zandi, T. Lereuil, F. Freiberg, M. Pfau, I. Pfister, C. Gerhardt, A. Meyenberg, S. Michels, L. Kodjikian, J. Garweg
Long-Term Intravitreal Dexamethasone Treatment in Eyes with Pretreated Chronic Diabetic Macular Edema
1.10.2017, Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, 33(8):620-628. doi: 10.1089/jop.2017.0020
J. Garweg, M. Deiss, C. Gerhardt, L. Kodjikian, I. Pfister
Real-Life Experience with Aflibercept and Ranibizumab in the Treatment of Newly Diagnosed Neovascular Age-Related Macular Degneration over 24 Months
1.9.2017, Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, 33(7):567-572. doi: 10.1089/jop.2017.0031
J. Garweg, S. Zandi, I. Pfister, M. Skowronska, C. Gerhardt
Comparison of cytokine profiles in the aqueous humor of eyes with pseudoexfolation syndrome and glaucoma
10.8.2017, Public Library of Science, 12(8):e0182571. doi: 10.1371/journal.pone.0182571
R. Nourinia, S. Nakao, S. Zandi, S. Safi, A. Hafezi-Moghadam, H. Ahmadieh
ROCK inhibitors for the treatment of ocular diseases
9.8.2017, The British journal of ophthalmology, pii: bjophthalmol-2017-310378. doi: 10.1136/bjophthalmol-2017-310378
J. Garweg, S. Zandi, C. Gerhardt, I. Pfister
Isoforms of TGF-beta in the aqueous humor of patients with pseudoexfolation syndrome and a possible association with the long-term stability of the capsular bag after cataract surgery.
28.6.2017, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 255(9):1763-1769. doi: 10.1007/s00417-017-3724-8
S. Zandi, F. Weisskopf, J. Garweg, M. Imesch, I. Pfister, C. Prünte, F. Sutter, K. Hatz
Pre-Existing RPE Atrophy and Defects in the External Limiting Membrane Predict Early Poor Visual Response to Ranibizumab in Neovascular Age-Related Macular Degeneration
1.4.2017, Ophthalmic surgery, lasers & imaging: the official journal of the International Society for Imaging in the Eye, 48(4):326-332. doi: 10.3928/23258160-20170329-07
J. Garweg, H. Russ, I. Pfister
Early Response to Ranibizumab Is Predictive of Treatment Demand after a Therapeutic Switch to Aflibercept
2017, Ophthalmology, 1:210-216
J. Garweg, S. Niderprim, H. Russ, I. Pfister
Comparison of Strategies of Treatment with Ranibizumab in Newly-Diagnosed Cases of Neovascular Age-Realated Macular Degeneration.
1.12.2016, Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, 33:773-778
S. Zandi, C. Tappeiner, I. Pfister, A. Despont, R. Rieben, J. Garweg
Vitreal Cytokine Profile Differences Between Eyes With Epiretinal Membranes or Macular Holes
1.11.2016, Investigative ophthalmology & visual science, 57(14):6320-6326. doi: 10.1167/iovs.16-20657
J. Garweg, E. Baglivo, F. Freiberg, M. Pfau, I. Pfister, S. Michels, S. Zandi
Response of Postoperative and Chronic Uveitic Cystoid Macular Edema to a Dexamethasone-Based Intravitreal Implant (Ozurdex)
1.9.2016, Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, 32(7):442-50
J. Garweg, S. Zandi
Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment
1.7.2016, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 1256-65
J. Garweg
Diabetische Retinopathie und Makulopathie nehmen zu
24.3.2016, Ars Medici (Schweizer Zeitschrift für Hausarztmedizin), 106:268-271
J. Garweg
Alterbedingte Makuladegeneration – Ursachen und Therapie
1.3.2015, Dialog, Dialog38 4-7
S. Wenger, C. Luvet, J. Garweg
Regionalanästhesie bei intraokularen Eingriffen
2015, Klinische Monatsblätter für Augenheilkunde, 232: 367-371
M. Wallon, J. Garweg, M. Abrahamowicz, C. Cornu, S. Vinault, C. Quantin, C. Bonithon-Kopp, S. Picot, F. Peyron, C. Binquet
Ophthalmic Outcomes of Congenital Toxoplasmosis
17.2.2014, Pediatrics, 2014 133(3):e601-8
F. Körner, U. Körner-Stiefbold, J. Garweg
Systemic corticosteroids reduce the risk of cellophane membranes after retinal detachment surgery: a prospective randomized placebo-controlled double-blind clinical trial
21.1.2012, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, Volume 250, Number 7 (2012), 981-987, DOI: 10.1007/s00417-011-1919-y
C. Tappeiner, F. Flückiger, M. Böhnke, D. Goldblum, J. Garweg
Effect of topical anesthetic agents and ethanol on corneoepithelial wound healing in an ex vivo whole-globe porcine model
2012, Journal of cataract and refractive surgery, 0886-3350, doi:10.1016/j.jcrs.2011.09.043
C. Tappeiner, J. Garweg
Retinal vascular occlusion after vitrectomy with retrobulbar anesthesia-observational case series and survey of literature
1.12.2011, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 249(12):1831-5
F. Peyron, J. Garweg, M. Wallon, E. Descolux, M. Rolland, J. Barth
Long-term Impact of Treated Congenital Toxoplasmosis on Quality of Life and Visual Performance
1.7.2011, The Pediatric Infectious Disease Journal, Volume 30, Number 7, July 2011
J. Garweg, C. Tappeiner
Differenzialdiagnose der infektiösen posterioren Uveitis
2011, Klinische Monatsblätter für Augenheilkunde, 2011 228: 268-272